Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Постмастэктомический синдром: вторичная лимфедема верхних конечностей после комбинированного лечения рака молочной железы (обзор литературы и собственные результаты)
Постмастэктомический синдром: вторичная лимфедема верхних конечностей после комбинированного лечения рака молочной железы (обзор литературы и собственные результаты)
Степанова А.М., Мерзлякова А.М., Хуламханова М.М., Трофимова О.П. Постмастэктомический синдром: вторичная лимфедема верхних конечностей после комбинированного лечения рака молочной железы (обзор литературы и собственные результаты). Современная Онкология. 2018; 20 (2): 45–49.
DOI: 10.26442/1815-1434_2018.2.45-49
DOI: 10.26442/1815-1434_2018.2.45-49
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Постмастэктомический синдром и лимфедема после комбинированного лечения рака молочной железы значительно ухудшает качество жизни пациенток, их психоэмоциональное состояние. Лечение данной патологии всегда носит комбинированный характер и включает в себя элементы полной противоотечной терапии, прессотерапию, селективную вазоактивную электростимуляцию и низкочастотную магнитотерапию. Наилучшие результаты терапии достигаются при раннем выявлении и начале лечения. Комплексное лечение лимфедемы не влияет на течение онкологического заболевания.
Ключевые слова: постмастэктомический синдром, лимфедема, комплексная реабилитация, рак молочной железы.
Key words: post-mastectomy syndrome, lymphedema, complex rehabilitation, breast cancer.
Ключевые слова: постмастэктомический синдром, лимфедема, комплексная реабилитация, рак молочной железы.
________________________________________________
Key words: post-mastectomy syndrome, lymphedema, complex rehabilitation, breast cancer.
Полный текст
Список литературы
1. Hill DA, Horick NK, Isaacs C et al. Long-term risk of medical conditions associated with breast cancer treatment. Breast Cancer Res Treat 2014; 145 (1): 233–43.
2. Hayes S, Di Sipio T, Rye S et al. Prevalence and prognostic significance of secondary lymphedema following breast cancer. Lymphat Res Biol 2011; 9 (3): 135–41.
3. Ashikaga T, Krag DN, Land SR et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 2010; 102 (2): 111–8.
4. Chachaj A, Malyszczak K, Pyszel K et al. Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psychooncology 2009; 19 (3): 299–305.
5. Ткаченко Г.А. Психологическая помощь на этапах реабилитации больных раком молочной железы. В кн.: Материалы Петербургского онкологического форума «Белые ночи-2017». СПб., 2017; с. 42–3. / Tkachenko G.A. Psikhologicheskaia pomoshch' na etapakh reabilitatsii bol'nykh rakom molochnoi zhelezy. V kn.: Materialy Peterburgskogo onkologicheskogo foruma “Belye nochi-2017”. SPb., 2017; s. 42–3. [in Russian]
6. Тишакова В.Э., Филоненко Е.В., Чиссов В.И. и др. Физические методы реабилитации онкологических больных после комбинированного лечения рака молочной железы. Biomedical Photonics. 2017; 6 (1): 28–37. / Tishakova V.E., Filonenko E.V., Chissov V.I. i dr. Fizicheskie metody reabilitatsii onkologicheskikh bol'nykh posle kombinirovannogo lecheniia raka molochnoi zhelezy. Biomedical Photonics. 2017; 6 (1): 28–37. [in Russian]
7. Shih YC, Xu Y, Cormier JN et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 2009; 27 (12): 2007–14.
8. Pereira R ACP, Koifman RJ, Bergmann A. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up. Breast 2017; 36: 67–73.
9. Ozcinar B, Guler SA, Kocaman N et al. Breast cancer related lymphedema in patients with different loco-regional treatments. Breast 2012; 21 (3): 361–5.
10. Ohsumi S, Shimozuma K, Ohashi Y et al. Subjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: The National Surgical Adjuvant Study of Breast Cancer 02. Oncology 2012; 82 (3): 131–8.
11. Hidding JT, Beurskens CHG, van der Wees PJ et al. Changes in volume and incidence of lymphedema during and after treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC) in patients with breast cancer. Support Care Cancer 2018; 26 (5): 1383–92.
12. Ridner SH, Dietrich MS, Stewart BR, Armer JM. Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer 2011; 19 (6): 853–7.
13. National Lymphedema Network. Supplement to National Lymphedema Network Position Statement Breast Cancer Screening. Screening and Early Detection of Breast Cancer-Related Lymphedema: The Imperative. http://www.lymphnet.org/pdfDocs/PP_Lymphedema_ BC_Supplement.pdf
14. Yamada S, Yamada Y, Kobayashi M et al. Post-mastectomy benign lymphangioendothelioma of the skin following chronic lymphedema for breast carcinoma: a teaching case mimicking low-grade angiosarcoma and masquerading as Stewart-Treves syndrome. Diagn Pathol 2014; 9 (1): 197.
15. Agbenorku P. Lymphedema: Complications and Management. Surg Sci 2014; 5: 290-8.
16. Vignes S. Lymphedema: From diagnosis to treatment. Rev Med Interne 2017; 38 (2): 97–105.
17. McLaughlin SA et al. Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel. Part 1: Definitions, Assessments, Education and Future Directions. Part 2: Preventive and Therapeutic Options. Ann Surg Oncol 2017; 24: 2818–35.
18. Adams KE, Rasmussen JC, Darne C et al. Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema. Biomed Opt Express 2010; 1 (1): 114–25.
19. Devoogdt N, Van Kampen M, Geraerts I et al. Different physical treatment modalities for lymphoedema developing after axillary lymph node dissection for breast cancer: a review. Eur J Obstet Gynecol Reprod Biol 2010; 149 (1): 3–9.
20. Boris M, Weindorf S, Lasinski BB. The risk of genital edema after external pump compression for lower limb lymphedema. Lymphology 1998; 31 (1): 15–20.
21. Karaca-Mandic P, Hirsch AT, Rockson SG, Ridner SH. The Cutaneous, Net Clinical, and Health Economic Benefits of Advanced Pneumatic Compression Devices in Patients With Lymphedema. JAMA Dermatol 2015; 151 (11): 1187–93.
22. Dirican A, Andacoglu O, Johnson R et al. The short-term effects of low-level laser therapy in the management of breast-cancerrelated lymphedema. Support Care Cancer 2011; 19 (5): 685–90.
23. Грушина Т.И. Реабилитация в онкологии: физиотерапия. М.: ГЭОТАР-Медиа, 2006. / Grushina T.I. Reabilitatsiia v onkologii: fizioterapiia. M.: GEOTAR-Media, 2006. [in Russian]
24. Lievens PC. The effect of combined HeNe and I.R. laser treatment on the regeneration of the lymphatic system during the process of wound healing. Lasers Med Sci 1991; 6 (2): 193–9.
25. Monteiro SE, Resende LV, Felicíssimo MF et al. Fisioter Mov 2014; 27 (4): 663–74.
26. Baxter GD, Liu L, Petrich S et al. Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: a systematic review. BMC Cancer 2017; 17: 833.
27. Weissleder H, Schuchhardt C. Anatomy (fundamentals). In: Lymphoedema Diagnosis and Treatment. Wesel, Baden-Baden, 2008.
28. Havas E, Lehtonen M, Vuorela J et al. Albumin clearance from human skeletal muscle during prolonged steady-state running. Exp Physiol 2000; 85 (6): 863–8.
29. Piller N, Douglass J, Heidenreich B, Moseley А. Placebo controlled trial of mild electrical stimulation. J Lymphoedema 2010; 5 (1).
30. Грушина Т.И. Какой метод физиотерапии постмастэктомической лимфедемы наиболее эффективен? Вопр. курортологии, физиотерапии и лечеб. физ. культуры. 2017; 94 (4): 59–66. / Grushina T.I. Kakoi metod fizioterapii postmastektomicheskoi limfedemy naibolee effektiven? Vopr. kurortologii, fizioterapii i lecheb. fiz. kul'tury. 2017; 94 (4): 59–66. [in Russian]
31. Wilburn O, Wilburn P, Rockson SG. A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema. BMC Cancer 2006; 6: 84.
32. Герасименко М.Ю., Князева Т.А., Апханова Т.В., Кульчицкая Д.Б. Применение метода кинезиотейпирования в немедикаментозной комплексной реабилитации больных лимфедемой нижних конечностей. Вопр. курортологии, физиотерапии и лечеб. физ. культуры. 2015; 92 (5): 22–7. / Gerasimenko M.Yu., Knyazeva T.A., Apkhanova T.V., Kul'chitskaya D.B. Primenenie metoda kinezioteipirovaniia v nemedikamentoznoi kompleksnoi reabilitatsii bol'nykh limfedemoi nizhnikh konechnostei. Vopr. kurortologii, fizioterapii i lecheb. fiz. kul'tury. 2015; 92 (5): 22–7. [in Russian]
33. Smykla A, Walewicz K, Trybulski T et al. Effect of Kinesiology Taping on Breast Cancer-Related Lymphedema: A Randomized Single-Blind Controlled Pilot Study. BioMed Research Int 2013; ID 767106: 7.
34. Mestre S, Calais, C, Gaillard G et al. Interest of an auto-adjustable nighttime compression sleeve (MOBIDERM Autofit) in maintenance phase of upper limb lymphedema: the MARILYN pilot RCT. Support Care Cancer 2017; 25: 2455.
2. Hayes S, Di Sipio T, Rye S et al. Prevalence and prognostic significance of secondary lymphedema following breast cancer. Lymphat Res Biol 2011; 9 (3): 135–41.
3. Ashikaga T, Krag DN, Land SR et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 2010; 102 (2): 111–8.
4. Chachaj A, Malyszczak K, Pyszel K et al. Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psychooncology 2009; 19 (3): 299–305.
5. Tkachenko G.A. Psikhologicheskaia pomoshch' na etapakh reabilitatsii bol'nykh rakom molochnoi zhelezy. V kn.: Materialy Peterburgskogo onkologicheskogo foruma “Belye nochi-2017”. SPb., 2017; s. 42–3. [in Russian]
6. Tishakova V.E., Filonenko E.V., Chissov V.I. i dr. Fizicheskie metody reabilitatsii onkologicheskikh bol'nykh posle kombinirovannogo lecheniia raka molochnoi zhelezy. Biomedical Photonics. 2017; 6 (1): 28–37. [in Russian]
7. Shih YC, Xu Y, Cormier JN et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 2009; 27 (12): 2007–14.
8. Pereira R ACP, Koifman RJ, Bergmann A. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up. Breast 2017; 36: 67–73.
9. Ozcinar B, Guler SA, Kocaman N et al. Breast cancer related lymphedema in patients with different loco-regional treatments. Breast 2012; 21 (3): 361–5.
10. Ohsumi S, Shimozuma K, Ohashi Y et al. Subjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: The National Surgical Adjuvant Study of Breast Cancer 02. Oncology 2012; 82 (3): 131–8.
11. Hidding JT, Beurskens CHG, van der Wees PJ et al. Changes in volume and incidence of lymphedema during and after treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC) in patients with breast cancer. Support Care Cancer 2018; 26 (5): 1383–92.
12. Ridner SH, Dietrich MS, Stewart BR, Armer JM. Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer 2011; 19 (6): 853–7.
13. National Lymphedema Network. Supplement to National Lymphedema Network Position Statement Breast Cancer Screening. Screening and Early Detection of Breast Cancer-Related Lymphedema: The Imperative. http://www.lymphnet.org/pdfDocs/PP_Lymphedema_ BC_Supplement.pdf
14. Yamada S, Yamada Y, Kobayashi M et al. Post-mastectomy benign lymphangioendothelioma of the skin following chronic lymphedema for breast carcinoma: a teaching case mimicking low-grade angiosarcoma and masquerading as Stewart-Treves syndrome. Diagn Pathol 2014; 9 (1): 197.
15. Agbenorku P. Lymphedema: Complications and Management. Surg Sci 2014; 5: 290-8.
16. Vignes S. Lymphedema: From diagnosis to treatment. Rev Med Interne 2017; 38 (2): 97–105.
17. McLaughlin SA et al. Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel. Part 1: Definitions, Assessments, Education and Future Directions. Part 2: Preventive and Therapeutic Options. Ann Surg Oncol 2017; 24: 2818–35.
18. Adams KE, Rasmussen JC, Darne C et al. Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema. Biomed Opt Express 2010; 1 (1): 114–25.
19. Devoogdt N, Van Kampen M, Geraerts I et al. Different physical treatment modalities for lymphoedema developing after axillary lymph node dissection for breast cancer: a review. Eur J Obstet Gynecol Reprod Biol 2010; 149 (1): 3–9.
20. Boris M, Weindorf S, Lasinski BB. The risk of genital edema after external pump compression for lower limb lymphedema. Lymphology 1998; 31 (1): 15–20.
21. Karaca-Mandic P, Hirsch AT, Rockson SG, Ridner SH. The Cutaneous, Net Clinical, and Health Economic Benefits of Advanced Pneumatic Compression Devices in Patients With Lymphedema. JAMA Dermatol 2015; 151 (11): 1187–93.
22. Dirican A, Andacoglu O, Johnson R et al. The short-term effects of low-level laser therapy in the management of breast-cancerrelated lymphedema. Support Care Cancer 2011; 19 (5): 685–90.
23. Grushina T.I. Reabilitatsiia v onkologii: fizioterapiia. M.: GEOTAR-Media, 2006. [in Russian]
24. Lievens PC. The effect of combined HeNe and I.R. laser treatment on the regeneration of the lymphatic system during the process of wound healing. Lasers Med Sci 1991; 6 (2): 193–9.
25. Monteiro SE, Resende LV, Felicíssimo MF et al. Fisioter Mov 2014; 27 (4): 663–74.
26. Baxter GD, Liu L, Petrich S et al. Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: a systematic review. BMC Cancer 2017; 17: 833.
27. Weissleder H, Schuchhardt C. Anatomy (fundamentals). In: Lymphoedema Diagnosis and Treatment. Wesel, Baden-Baden, 2008.
28. Havas E, Lehtonen M, Vuorela J et al. Albumin clearance from human skeletal muscle during prolonged steady-state running. Exp Physiol 2000; 85 (6): 863–8.
29. Piller N, Douglass J, Heidenreich B, Moseley А. Placebo controlled trial of mild electrical stimulation. J Lymphoedema 2010; 5 (1).
30. Grushina T.I. Kakoi metod fizioterapii postmastektomicheskoi limfedemy naibolee effektiven? Vopr. kurortologii, fizioterapii i lecheb. fiz. kul'tury. 2017; 94 (4): 59–66. [in Russian]
31. Wilburn O, Wilburn P, Rockson SG. A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema. BMC Cancer 2006; 6: 84.
32. Gerasimenko M.Yu., Knyazeva T.A., Apkhanova T.V., Kul'chitskaya D.B. Primenenie metoda kinezioteipirovaniia v nemedikamentoznoi kompleksnoi reabilitatsii bol'nykh limfedemoi nizhnikh konechnostei. Vopr. kurortologii, fizioterapii i lecheb. fiz. kul'tury. 2015; 92 (5): 22–7. [in Russian]
33. Smykla A, Walewicz K, Trybulski T et al. Effect of Kinesiology Taping on Breast Cancer-Related Lymphedema: A Randomized Single-Blind Controlled Pilot Study. BioMed Research Int 2013; ID 767106: 7.
34. Mestre S, Calais, C, Gaillard G et al. Interest of an auto-adjustable nighttime compression sleeve (MOBIDERM Autofit) in maintenance phase of upper limb lymphedema: the MARILYN pilot RCT. Support Care Cancer 2017; 25: 2455.
2. Hayes S, Di Sipio T, Rye S et al. Prevalence and prognostic significance of secondary lymphedema following breast cancer. Lymphat Res Biol 2011; 9 (3): 135–41.
3. Ashikaga T, Krag DN, Land SR et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 2010; 102 (2): 111–8.
4. Chachaj A, Malyszczak K, Pyszel K et al. Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psychooncology 2009; 19 (3): 299–305.
5. Ткаченко Г.А. Психологическая помощь на этапах реабилитации больных раком молочной железы. В кн.: Материалы Петербургского онкологического форума «Белые ночи-2017». СПб., 2017; с. 42–3. / Tkachenko G.A. Psikhologicheskaia pomoshch' na etapakh reabilitatsii bol'nykh rakom molochnoi zhelezy. V kn.: Materialy Peterburgskogo onkologicheskogo foruma “Belye nochi-2017”. SPb., 2017; s. 42–3. [in Russian]
6. Тишакова В.Э., Филоненко Е.В., Чиссов В.И. и др. Физические методы реабилитации онкологических больных после комбинированного лечения рака молочной железы. Biomedical Photonics. 2017; 6 (1): 28–37. / Tishakova V.E., Filonenko E.V., Chissov V.I. i dr. Fizicheskie metody reabilitatsii onkologicheskikh bol'nykh posle kombinirovannogo lecheniia raka molochnoi zhelezy. Biomedical Photonics. 2017; 6 (1): 28–37. [in Russian]
7. Shih YC, Xu Y, Cormier JN et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 2009; 27 (12): 2007–14.
8. Pereira R ACP, Koifman RJ, Bergmann A. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up. Breast 2017; 36: 67–73.
9. Ozcinar B, Guler SA, Kocaman N et al. Breast cancer related lymphedema in patients with different loco-regional treatments. Breast 2012; 21 (3): 361–5.
10. Ohsumi S, Shimozuma K, Ohashi Y et al. Subjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: The National Surgical Adjuvant Study of Breast Cancer 02. Oncology 2012; 82 (3): 131–8.
11. Hidding JT, Beurskens CHG, van der Wees PJ et al. Changes in volume and incidence of lymphedema during and after treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC) in patients with breast cancer. Support Care Cancer 2018; 26 (5): 1383–92.
12. Ridner SH, Dietrich MS, Stewart BR, Armer JM. Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer 2011; 19 (6): 853–7.
13. National Lymphedema Network. Supplement to National Lymphedema Network Position Statement Breast Cancer Screening. Screening and Early Detection of Breast Cancer-Related Lymphedema: The Imperative. http://www.lymphnet.org/pdfDocs/PP_Lymphedema_ BC_Supplement.pdf
14. Yamada S, Yamada Y, Kobayashi M et al. Post-mastectomy benign lymphangioendothelioma of the skin following chronic lymphedema for breast carcinoma: a teaching case mimicking low-grade angiosarcoma and masquerading as Stewart-Treves syndrome. Diagn Pathol 2014; 9 (1): 197.
15. Agbenorku P. Lymphedema: Complications and Management. Surg Sci 2014; 5: 290-8.
16. Vignes S. Lymphedema: From diagnosis to treatment. Rev Med Interne 2017; 38 (2): 97–105.
17. McLaughlin SA et al. Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel. Part 1: Definitions, Assessments, Education and Future Directions. Part 2: Preventive and Therapeutic Options. Ann Surg Oncol 2017; 24: 2818–35.
18. Adams KE, Rasmussen JC, Darne C et al. Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema. Biomed Opt Express 2010; 1 (1): 114–25.
19. Devoogdt N, Van Kampen M, Geraerts I et al. Different physical treatment modalities for lymphoedema developing after axillary lymph node dissection for breast cancer: a review. Eur J Obstet Gynecol Reprod Biol 2010; 149 (1): 3–9.
20. Boris M, Weindorf S, Lasinski BB. The risk of genital edema after external pump compression for lower limb lymphedema. Lymphology 1998; 31 (1): 15–20.
21. Karaca-Mandic P, Hirsch AT, Rockson SG, Ridner SH. The Cutaneous, Net Clinical, and Health Economic Benefits of Advanced Pneumatic Compression Devices in Patients With Lymphedema. JAMA Dermatol 2015; 151 (11): 1187–93.
22. Dirican A, Andacoglu O, Johnson R et al. The short-term effects of low-level laser therapy in the management of breast-cancerrelated lymphedema. Support Care Cancer 2011; 19 (5): 685–90.
23. Грушина Т.И. Реабилитация в онкологии: физиотерапия. М.: ГЭОТАР-Медиа, 2006. / Grushina T.I. Reabilitatsiia v onkologii: fizioterapiia. M.: GEOTAR-Media, 2006. [in Russian]
24. Lievens PC. The effect of combined HeNe and I.R. laser treatment on the regeneration of the lymphatic system during the process of wound healing. Lasers Med Sci 1991; 6 (2): 193–9.
25. Monteiro SE, Resende LV, Felicíssimo MF et al. Fisioter Mov 2014; 27 (4): 663–74.
26. Baxter GD, Liu L, Petrich S et al. Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: a systematic review. BMC Cancer 2017; 17: 833.
27. Weissleder H, Schuchhardt C. Anatomy (fundamentals). In: Lymphoedema Diagnosis and Treatment. Wesel, Baden-Baden, 2008.
28. Havas E, Lehtonen M, Vuorela J et al. Albumin clearance from human skeletal muscle during prolonged steady-state running. Exp Physiol 2000; 85 (6): 863–8.
29. Piller N, Douglass J, Heidenreich B, Moseley А. Placebo controlled trial of mild electrical stimulation. J Lymphoedema 2010; 5 (1).
30. Грушина Т.И. Какой метод физиотерапии постмастэктомической лимфедемы наиболее эффективен? Вопр. курортологии, физиотерапии и лечеб. физ. культуры. 2017; 94 (4): 59–66. / Grushina T.I. Kakoi metod fizioterapii postmastektomicheskoi limfedemy naibolee effektiven? Vopr. kurortologii, fizioterapii i lecheb. fiz. kul'tury. 2017; 94 (4): 59–66. [in Russian]
31. Wilburn O, Wilburn P, Rockson SG. A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema. BMC Cancer 2006; 6: 84.
32. Герасименко М.Ю., Князева Т.А., Апханова Т.В., Кульчицкая Д.Б. Применение метода кинезиотейпирования в немедикаментозной комплексной реабилитации больных лимфедемой нижних конечностей. Вопр. курортологии, физиотерапии и лечеб. физ. культуры. 2015; 92 (5): 22–7. / Gerasimenko M.Yu., Knyazeva T.A., Apkhanova T.V., Kul'chitskaya D.B. Primenenie metoda kinezioteipirovaniia v nemedikamentoznoi kompleksnoi reabilitatsii bol'nykh limfedemoi nizhnikh konechnostei. Vopr. kurortologii, fizioterapii i lecheb. fiz. kul'tury. 2015; 92 (5): 22–7. [in Russian]
33. Smykla A, Walewicz K, Trybulski T et al. Effect of Kinesiology Taping on Breast Cancer-Related Lymphedema: A Randomized Single-Blind Controlled Pilot Study. BioMed Research Int 2013; ID 767106: 7.
34. Mestre S, Calais, C, Gaillard G et al. Interest of an auto-adjustable nighttime compression sleeve (MOBIDERM Autofit) in maintenance phase of upper limb lymphedema: the MARILYN pilot RCT. Support Care Cancer 2017; 25: 2455.
________________________________________________
2. Hayes S, Di Sipio T, Rye S et al. Prevalence and prognostic significance of secondary lymphedema following breast cancer. Lymphat Res Biol 2011; 9 (3): 135–41.
3. Ashikaga T, Krag DN, Land SR et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 2010; 102 (2): 111–8.
4. Chachaj A, Malyszczak K, Pyszel K et al. Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psychooncology 2009; 19 (3): 299–305.
5. Tkachenko G.A. Psikhologicheskaia pomoshch' na etapakh reabilitatsii bol'nykh rakom molochnoi zhelezy. V kn.: Materialy Peterburgskogo onkologicheskogo foruma “Belye nochi-2017”. SPb., 2017; s. 42–3. [in Russian]
6. Tishakova V.E., Filonenko E.V., Chissov V.I. i dr. Fizicheskie metody reabilitatsii onkologicheskikh bol'nykh posle kombinirovannogo lecheniia raka molochnoi zhelezy. Biomedical Photonics. 2017; 6 (1): 28–37. [in Russian]
7. Shih YC, Xu Y, Cormier JN et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 2009; 27 (12): 2007–14.
8. Pereira R ACP, Koifman RJ, Bergmann A. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up. Breast 2017; 36: 67–73.
9. Ozcinar B, Guler SA, Kocaman N et al. Breast cancer related lymphedema in patients with different loco-regional treatments. Breast 2012; 21 (3): 361–5.
10. Ohsumi S, Shimozuma K, Ohashi Y et al. Subjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: The National Surgical Adjuvant Study of Breast Cancer 02. Oncology 2012; 82 (3): 131–8.
11. Hidding JT, Beurskens CHG, van der Wees PJ et al. Changes in volume and incidence of lymphedema during and after treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC) in patients with breast cancer. Support Care Cancer 2018; 26 (5): 1383–92.
12. Ridner SH, Dietrich MS, Stewart BR, Armer JM. Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer 2011; 19 (6): 853–7.
13. National Lymphedema Network. Supplement to National Lymphedema Network Position Statement Breast Cancer Screening. Screening and Early Detection of Breast Cancer-Related Lymphedema: The Imperative. http://www.lymphnet.org/pdfDocs/PP_Lymphedema_ BC_Supplement.pdf
14. Yamada S, Yamada Y, Kobayashi M et al. Post-mastectomy benign lymphangioendothelioma of the skin following chronic lymphedema for breast carcinoma: a teaching case mimicking low-grade angiosarcoma and masquerading as Stewart-Treves syndrome. Diagn Pathol 2014; 9 (1): 197.
15. Agbenorku P. Lymphedema: Complications and Management. Surg Sci 2014; 5: 290-8.
16. Vignes S. Lymphedema: From diagnosis to treatment. Rev Med Interne 2017; 38 (2): 97–105.
17. McLaughlin SA et al. Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel. Part 1: Definitions, Assessments, Education and Future Directions. Part 2: Preventive and Therapeutic Options. Ann Surg Oncol 2017; 24: 2818–35.
18. Adams KE, Rasmussen JC, Darne C et al. Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema. Biomed Opt Express 2010; 1 (1): 114–25.
19. Devoogdt N, Van Kampen M, Geraerts I et al. Different physical treatment modalities for lymphoedema developing after axillary lymph node dissection for breast cancer: a review. Eur J Obstet Gynecol Reprod Biol 2010; 149 (1): 3–9.
20. Boris M, Weindorf S, Lasinski BB. The risk of genital edema after external pump compression for lower limb lymphedema. Lymphology 1998; 31 (1): 15–20.
21. Karaca-Mandic P, Hirsch AT, Rockson SG, Ridner SH. The Cutaneous, Net Clinical, and Health Economic Benefits of Advanced Pneumatic Compression Devices in Patients With Lymphedema. JAMA Dermatol 2015; 151 (11): 1187–93.
22. Dirican A, Andacoglu O, Johnson R et al. The short-term effects of low-level laser therapy in the management of breast-cancerrelated lymphedema. Support Care Cancer 2011; 19 (5): 685–90.
23. Grushina T.I. Reabilitatsiia v onkologii: fizioterapiia. M.: GEOTAR-Media, 2006. [in Russian]
24. Lievens PC. The effect of combined HeNe and I.R. laser treatment on the regeneration of the lymphatic system during the process of wound healing. Lasers Med Sci 1991; 6 (2): 193–9.
25. Monteiro SE, Resende LV, Felicíssimo MF et al. Fisioter Mov 2014; 27 (4): 663–74.
26. Baxter GD, Liu L, Petrich S et al. Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: a systematic review. BMC Cancer 2017; 17: 833.
27. Weissleder H, Schuchhardt C. Anatomy (fundamentals). In: Lymphoedema Diagnosis and Treatment. Wesel, Baden-Baden, 2008.
28. Havas E, Lehtonen M, Vuorela J et al. Albumin clearance from human skeletal muscle during prolonged steady-state running. Exp Physiol 2000; 85 (6): 863–8.
29. Piller N, Douglass J, Heidenreich B, Moseley А. Placebo controlled trial of mild electrical stimulation. J Lymphoedema 2010; 5 (1).
30. Grushina T.I. Kakoi metod fizioterapii postmastektomicheskoi limfedemy naibolee effektiven? Vopr. kurortologii, fizioterapii i lecheb. fiz. kul'tury. 2017; 94 (4): 59–66. [in Russian]
31. Wilburn O, Wilburn P, Rockson SG. A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema. BMC Cancer 2006; 6: 84.
32. Gerasimenko M.Yu., Knyazeva T.A., Apkhanova T.V., Kul'chitskaya D.B. Primenenie metoda kinezioteipirovaniia v nemedikamentoznoi kompleksnoi reabilitatsii bol'nykh limfedemoi nizhnikh konechnostei. Vopr. kurortologii, fizioterapii i lecheb. fiz. kul'tury. 2015; 92 (5): 22–7. [in Russian]
33. Smykla A, Walewicz K, Trybulski T et al. Effect of Kinesiology Taping on Breast Cancer-Related Lymphedema: A Randomized Single-Blind Controlled Pilot Study. BioMed Research Int 2013; ID 767106: 7.
34. Mestre S, Calais, C, Gaillard G et al. Interest of an auto-adjustable nighttime compression sleeve (MOBIDERM Autofit) in maintenance phase of upper limb lymphedema: the MARILYN pilot RCT. Support Care Cancer 2017; 25: 2455.
Авторы
А.М.Степанова*1, А.М.Мерзлякова1, М.М.Хуламханова1, О.П.Трофимова1,2
1 ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н.Блохина» Минздрава России. 115478, Россия, Москва, Каширское ш., д. 23;
2 ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России. 123995, Россия, Москва, ул. Баррикадная, д. 2/1
*stepanovas@list.ru
1 N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation. 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23;
2 Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation. 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
*stepanovas@list.ru
1 ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н.Блохина» Минздрава России. 115478, Россия, Москва, Каширское ш., д. 23;
2 ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России. 123995, Россия, Москва, ул. Баррикадная, д. 2/1
*stepanovas@list.ru
________________________________________________
1 N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation. 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23;
2 Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation. 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
*stepanovas@list.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.